CSF2 and central nervous system cancer: Taken together, the upregulation of CCL2 and GM-CSF in regrown tumors detected in our study suggests increased TIM infiltration and proliferation in relapsed tumors, an immunosuppressive shift in the tumor microenvironment, and enhanced glioma cell motility.